TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
CADL

Candel Therapeutics Inc

Healthcare · Biotechnology

11.00$ -4.6% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CADL
Line item 2019 2020 2021 2022 2023 2024 2025
– -16.6% +133.0% -12.0% -47.5% +159.4% +17.2%
– -22.3% +141.7% -15.3% -48.9% +182.1% +15.3%
– +576.8% +135.8% -15.2% -49.5% +189.9% +16.6%
– -22.2% +135.8% -15.2% -49.5% +189.9% +16.6%
– +555.8% +37.6% +42.9% – – –
– +14.7% -59.5% +22.9% -7.6% +42.5% +80.7%
– +234.3% +13.8% +4.7% +152.6% +164.6% -76.0%
– – – – +1,927.2% +11.2% -95.7%
– +322.5% +72.6% -76.1% +11.1% -43.8% +376.4%
– +15.0% +15.9% +3,623.2% -40.6% -79.0% +1,710.6%
– – – -25.6% -73.3% +420.4% -21.7%
– – – – – – –
– +0.0% +0.8% +52.7% +0.4% +9.5% +67.2%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?